Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 3/15/21 → 3/14/23 |
Funding
- Massachusetts General Hospital (Ajroud-Driss AGMT 4/19/21)
- Biohaven Pharmaceuticals, Inc. (Ajroud-Driss AGMT 4/19/21)
HEALEY ALS Platform Trial Regimen-Specific Appendix (RSA) B to Master Protocol Verdiperstat | Home Spirometry and Open-Label Extension (OLE) Period
- Ajroud-Driss, Senda (PD/PI)
Project: Research project